0
0
7/8/21 at 9:03pm
Organization
CNBC
Author
Berkeley Lovelace Jr.
31 words
0
Comments
Clinical studies could begin as early as August, subject to regulatory approvals, Pfizer says.
You are the first to view
https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html
Create an account
or login to join the discussion